Exodus Point Capital Management, LP Regulus Therapeutics Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 329,639 shares of RGLS stock, worth $530,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
329,639Holding current value
$530,718% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
65Shares Held
52.6MCall Options Held
155KPut Options Held
34.2K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$20.7 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.25MShares$10.1 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$8.05 Million1.32% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.86 Million1.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.05MShares$6.52 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $23.6M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...